Sub-regional analysis of the parotid glands: model development for predicting late xerostomia with radiomics features in head and neck cancer patients

Authors

  • Thomas Berger a Department of Oncology Physics, Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK; b Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK
  • David J. Noble b Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK;c Department of Oncology, The University of Cambridge, Cambridge, UK; d Department of Clinical Oncology, Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK
  • Zhuolin Yang a Department of Oncology Physics, Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK; e School of Engineering, the University of Edinburgh, the King’s Buildings, Edinburgh, UK
  • Leila EA. Shelley a Department of Oncology Physics, Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK
  • Thomas McMullan a Department of Oncology Physics, Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK
  • Amy Bates c Department of Oncology, The University of Cambridge, Cambridge, UK
  • Simon Thomas f Department of Medical Physics and Clinical Engineering, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
  • Linda J. Carruthers a Department of Oncology Physics, Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK
  • George Beckett g Edinburgh Parallel Computing Centre, Bayes Centre, Edinburgh, UK
  • Aileen Duffton h Beatson West of Scotland Cancer Centre, Glasgow, UK
  • Claire Paterson h Beatson West of Scotland Cancer Centre, Glasgow, UK
  • Raj Jena c Department of Oncology, The University of Cambridge, Cambridge, UK
  • Duncan B. McLaren d Department of Clinical Oncology, Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK
  • Neil G. Burnet i The Christie NHS Foundation Trust, Manchester, UK
  • William H. Nailon a Department of Oncology Physics, Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK; e School of Engineering, the University of Edinburgh, the King’s Buildings, Edinburgh, UK

DOI:

https://doi.org/10.1080/0284186X.2023.2179895

Keywords:

Radiomics, stem cells, xerostomia, parotid, head and neck cancer, image analysis

Abstract

Background

The irradiation of sub-regions of the parotid has been linked to xerostomia development in patients with head and neck cancer (HNC). In this study, we compared the xerostomia classification performance of radiomics features calculated on clinically relevant and de novo sub-regions of the parotid glands of HNC patients.

Material and Methods

All patients (N = 117) were treated with TomoTherapy in 30–35 fractions of 2–2.167 Gy per fraction with daily mega-voltage-CT (MVCT) acquisition for image-guidance purposes. Radiomics features (N = 123) were extracted from daily MVCTs for the whole parotid gland and nine sub-regions. The changes in feature values after each complete week of treatment were considered as predictors of xerostomia (CTCAEv4.03, grade ≥ 2) at 6 and 12 months. Combinations of predictors were generated following the removal of statistically redundant information and stepwise selection. The classification performance of the logistic regression models was evaluated on train and test sets of patients using the Area Under the Curve (AUC) associated with the different sub-regions at each week of treatment and benchmarked with the performance of models solely using dose and toxicity at baseline.

Results

In this study, radiomics-based models predicted xerostomia better than standard clinical predictors. Models combining dose to the parotid and xerostomia scores at baseline yielded an AUCtest of 0.63 and 0.61 for xerostomia prediction at 6 and 12 months after radiotherapy while models based on radiomics features extracted from the whole parotid yielded a maximum AUCtest of 0.67 and 0.75, respectively. Overall, across sub-regions, maximum AUCtest was 0.76 and 0.80 for xerostomia prediction at 6 and 12 months. Within the first two weeks of treatment, the cranial part of the parotid systematically yielded the highest AUCtest.

Conclusion

Our results indicate that variations of radiomics features calculated on sub-regions of the parotid glands can lead to earlier and improved prediction of xerostomia in HNC patients.

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2023-02-01

How to Cite

Berger, T., Noble, D. J., Yang, Z., Shelley, L. E., McMullan, T., Bates, A., … Nailon, W. H. (2023). Sub-regional analysis of the parotid glands: model development for predicting late xerostomia with radiomics features in head and neck cancer patients. Acta Oncologica, 62(2), 166–173. https://doi.org/10.1080/0284186X.2023.2179895